Tag: Illumina

Innovation, Research

Illumina and GenoScreen introduce new tuberculosis test

March 27, 2023

Via: Medical Device Network

Biotechnology firm Illumina and genomics company GenoScreen have introduced a new package that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a next-generation sequencing (NGS)-based test for Tuberculosis (TB). As a targeted NGS-based test, the Deeplex Myc-TB assay […]

Biomarker, Innovation

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

January 5, 2022

Via: HitConsultant

Biomarker testing is used not only to select the most appropriate targeted oncology therapy available on the market for a particular patient but also to determine whether a patient’s best course of action is to receive an experimental therapy as […]

Biomarker, Innovation

Illumina in talks to acquire cancer blood test developer Grail

September 17, 2020


US-based biotechnology company Illumina is in talks to acquire cancer blood test developer Grail. Illumina is likely to pay more than $8bn for Grail, which is valued at approximately $6bn from its previous fundraisings, Bloomberg reported. According to the regulatory […]

Innovation, Med Tech

Equipment for single-cell genomics released by Illumina and Bio-Rad

January 12, 2017

Via: The Medical News

Illumina, Inc. and Bio-Rad Laboratories, Inc. today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability […]

Innovation, Research

Company Will Raise $1 Billion To Create Blood Test To Detect Cancer

January 6, 2017

Via: Forbes

Grail, a San Francisco startup that aims to invent a blood test that can detect cancer early, announced this afternoon that it plans to raise $1 billion in venture capital in its second financing round, a sum that puts the biotech […]